Xaira Therapeutics
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Full Xaira Therapeutics record →Head to head
Xaira Therapeutics (Xaira Therapeutics) and Altos Labs (Altos Labs) both sit in Science & Bio. Every value below comes from the latest crawl of the vendors' own pages.
| Attribute | Xaira Therapeutics Xaira Therapeutics | Altos Labs Altos Labs |
|---|---|---|
| Segment | Science & Bio | Science & Bio |
| Version | X-Atlas/Pisces and X-Cell | Cellular Rejuvenation Programming |
| Entry cost | Enterprise/proprietary drug discovery platform, no public pricing or individual tiers | Biotech company, not a software product. No commercial software/API pricing. |
| Pricing tiers | — | — |
| Model stack | Proprietary | Proprietary |
| Context window | — | — |
| Public API | ||
| Routes models | ||
| Changes / 30d | 6 | 6 |
| Origin | United States | United States |
| Capabilities | Generative protein design, Perturbation atlases, Wet-lab loop, predictive AI models, agentic AI models, virtual cells, drug discovery, AI models for drug discovery | Cell reprogramming, ML-guided biology, Longevity research |
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Full Xaira Therapeutics record →Machine-learning-guided reprogramming research aimed at reversing cellular ageing.
Full Altos Labs record →